PFIZER INC — Director's Dealing 2019

Mar 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-03-01

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-01	Common Stock	M	57609.0000	$30.5900	Acquired	390097.0000	Direct
2019-03-01	Common Stock	M	48582.0000	$32.2300	Acquired	438679.0000	Direct
2019-03-01	Common Stock	S	2300.0000	$43.5900	Disposed	436379.0000	Direct
2019-03-01	Common Stock	S	5927.0000	$43.5800	Disposed	430452.0000	Direct
2019-03-01	Common Stock	S	14760.0000	$43.5700	Disposed	415692.0000	Direct
2019-03-01	Common Stock	S	77484.0000	$43.5600	Disposed	338208.0000	Direct
2019-03-04	Common Stock	S	2187.0000	$43.5600	Disposed	336021.0000	Direct
2019-03-04	Common Stock	S	2400.0000	$43.5500	Disposed	333621.0000	Direct
2019-03-04	Common Stock	S	2600.0000	$43.5400	Disposed	331021.0000	Direct
2019-03-04	Common Stock	S	3250.0000	$43.5300	Disposed	327771.0000	Direct
2019-03-04	Common Stock	S	38645.0000	$43.5200	Disposed	289126.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-01	Stock Appreciation Rights	$30.5900	M	155172.0000	Disposed	2021-02-25	Common Stock (155172.0000)	Direct
2019-03-01	Stock Appreciation Rights	$32.2300	M	126366.0000	Disposed	2021-02-27	Common Stock (126366.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1625.0000	Indirect

Footnotes

F1: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $42.45)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant.

F2: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $42.45)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant.